Phlebitis: A swelling of veins, phlebitis can cause pain, tenderness, or swelling in the affected area as well as warmth and ...

If approved, Eylea would be the first treatment for RVO with 8-week dosing. The FDA target action date is Aug. 19, 2025.

Dupilumab in atopic dermatitis treatment had the most favorable cardiometabolic safety profile when compared with methotrexate and cyclosporine.

NJ Top Docs practice, The Cardiovascular Care Group enhances access to expert care with the opening of its newest office in Denville, New ...

About Retinal Vein Occlusion RVO is a common ... and transformed the treatment paradigm for certain serious chorioretinal vascular diseases. With a well-established efficacy and consistent safety ...

The first inkling that drummer Zak Starkey had that something might be amiss, was a feeling of 'muscle tightness' in his ...

Some vascular surgeons believe that the effect ... Mr Greenstein says his patients have been delighted with their keyhole vein treatment. One of them was back on the golf course playing a full ...

Experiencing constant cold feet and a sense of heaviness in your legs? These may not just be signs of fatigue or poor circulation—they could be early indicators of varicose veins, a condition now ...

The US Food and Drug Administration (FDA) has accepted Regeneron Pharmaceuticals’ supplemental biologics licence application ...

A study in patients with solid tumors found that CRBSI is significantly linked to mortality in patients with PICCs, whereas CRT and CRLC are not significant risk factors.